Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1991 Feb;72(2):304–311.

Effect of variations in peptide sequence on anti-human milk fat globule membrane antibody reactions.

P X Xing 1, K Reynolds 1, G A Pietersz 1, I F McKenzie 1
PMCID: PMC1384501  PMID: 1707852

Abstract

Monoclonal anti-mucine antibodies BC1, BC2 and BC3 produced using human milk fat globule membrane react with a synthetic peptide p1-24 (PDTRPAPGSTAPPAHGVTSAPDTR) representing the repeating amino acid sequence of the mucin core protein. The minimum epitope recognized by these three monoclonal antibodies (mAb) in p1-24 was contained in the five amino acids APDTR. To analyse the variation of position of the epitope, various modifications of the APDTR sequence were made by synthesizing peptides and testing by direct binding and inhibition enzyme-linked immunosorbent assays. Firstly, peptides p13-32 and C-p13-32, in which the epitope APDTR was placed in the middle instead of the C-terminal as in p1-24, were examined. These peptides had a greater reaction with mAb BC1, BC2 and BC3 compared with the reaction with p1-24. Secondly, A-p1-24 and TSA-p1-24 were made wherein two APDTR epitopes were present--these peptides were shown to bind two IgG antibody molecules. Finally, the contribution of each amino acid in the APDTR epitope was studied using the pepscan polyethylene rods, making all 20 of the amino acid substitutions in each position for SAPDTR (the minimum epitope APDTR with an adjacent amino acid S). In the 120 peptides examined there were some 'permissible' substitutions in A, D and T but not in P or R for BC1 and BC2; there were more 'permissible' substitutions for BC3; different substitution patterns were found with each antibody and some substitutions gave an increased reaction compared with the native peptide SAPDTR. The studies are of value in analysing the reaction of antibodies with epitopes expressed in breast cancer and in determining the antigenicity of synthetic peptides.

Full text

PDF
304

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burchell J., Gendler S., Taylor-Papadimitriou J., Girling A., Lewis A., Millis R., Lamport D. Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res. 1987 Oct 15;47(20):5476–5482. [PubMed] [Google Scholar]
  2. Burchell J., Taylor-Papadimitriou J., Boshell M., Gendler S., Duhig T. A short sequence, within the amino acid tandem repeat of a cancer-associated mucin, contains immunodominant epitopes. Int J Cancer. 1989 Oct 15;44(4):691–696. doi: 10.1002/ijc.2910440423. [DOI] [PubMed] [Google Scholar]
  3. Gendler S. J., Burchell J. M., Duhig T., Lamport D., White R., Parker M., Taylor-Papadimitriou J. Cloning of partial cDNA encoding differentiation and tumor-associated mucin glycoproteins expressed by human mammary epithelium. Proc Natl Acad Sci U S A. 1987 Sep;84(17):6060–6064. doi: 10.1073/pnas.84.17.6060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gendler S., Taylor-Papadimitriou J., Duhig T., Rothbard J., Burchell J. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J Biol Chem. 1988 Sep 15;263(26):12820–12823. [PubMed] [Google Scholar]
  5. Geysen H. M., Mason T. J., Rodda S. J. Cognitive features of continuous antigenic determinants. J Mol Recognit. 1988 Feb;1(1):32–41. doi: 10.1002/jmr.300010107. [DOI] [PubMed] [Google Scholar]
  6. Hopp T. P., Woods K. R. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3824–3828. doi: 10.1073/pnas.78.6.3824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Price M. R. High molecular weight epithelial mucins as markers in breast cancer. Eur J Cancer Clin Oncol. 1988 Dec;24(12):1799–1804. doi: 10.1016/0277-5379(88)90088-0. [DOI] [PubMed] [Google Scholar]
  8. Riddles P. W., Blakeley R. L., Zerner B. Reassessment of Ellman's reagent. Methods Enzymol. 1983;91:49–60. doi: 10.1016/s0076-6879(83)91010-8. [DOI] [PubMed] [Google Scholar]
  9. Siddiqui J., Abe M., Hayes D., Shani E., Yunis E., Kufe D. Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc Natl Acad Sci U S A. 1988 Apr;85(7):2320–2323. doi: 10.1073/pnas.85.7.2320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Welling G. W., Weijer W. J., van der Zee R., Welling-Wester S. Prediction of sequential antigenic regions in proteins. FEBS Lett. 1985 Sep 2;188(2):215–218. doi: 10.1016/0014-5793(85)80374-4. [DOI] [PubMed] [Google Scholar]
  11. Xing P. X., Reynolds K., Tjandra J. J., Tang X. L., McKenzie I. F. Synthetic peptides reactive with anti-human milk fat globule membrane monoclonal antibodies. Cancer Res. 1990 Jan 1;50(1):89–96. [PubMed] [Google Scholar]
  12. Xing P. X., Tjandra J. J., Reynolds K., McLaughlin P. J., Purcell D. F., McKenzie I. F. Reactivity of anti-human milk fat globule antibodies with synthetic peptides. J Immunol. 1989 May 15;142(10):3503–3509. [PubMed] [Google Scholar]
  13. Xing P. X., Tjandra J. J., Stacker S. A., Teh J. G., Thompson C. H., McLaughlin P. J., McKenzie I. F. Monoclonal antibodies reactive with mucin expressed in breast cancer. Immunol Cell Biol. 1989 Jun;67(Pt 3):183–195. doi: 10.1038/icb.1989.29. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES